Advisors

Nicholas Barnes, PhD

Dr. Barnes is a globally recognized expert in the field of serotonin (5-HT) pharmacology, particularly with the 5-HT3 receptor. He is the principal founder and CEO of Celentyx Ltd, a venture capital financed pharmaceutical R&D company focusing on diseases of the immune system, and has a proven track record in the investigation of drug targets and the delivery of development compounds. He is also a Fellow of the British Pharmacological Society and an Honorary Prof. at several major universities around the globe as well as being Editor-in-Chief, Editor and Associate Editor for Frontiers in Neuropharmacology, Neuropharmacology, and Frontiers in Neuroscience, respectively.

Douglas A. Drossman, MD

Dr. Drossman is the President of Drossman Consulting LLC, Drossman Gastroenterology, PLLC, and the President of the Rome Foundation. He is the former Co-Director of University of North Carolina (UNC) Center for Functional GI and Motility Disorders (FGIDs) and Professor Emeritus of Medicine and Psychiatry at UNC. Dr. Drossman is an internationally recognized key opinion leader in the field of FGIDs. During his career as a physician, scientist and patient advocate, he has written over 500 articles and book chapters and published four books including GI Procedure Manual (now in 4th edition) and the textbook of Functional GI disorders (Rome I, II, III, IV) with Rome IV released in May 2016. He has served on multiple advisory boards of NIH, academic and industry organizations. Dr. Drossman is the recipient of numerous awards and grants.

Shayne Gad, PhD, DABT

Founder and Principle of Gad Consulting Services and an expert in toxicology and regulatory affairs. Dr.Gad has contributed to the filing of over 100 INDs. He was the president of the American College of Toxicology and the Roundtable of Toxicology Consultants and the recipient of the 2008 ACT Lifetime Achievement Award.

Stephen Harrison, MD

Dr. Harrison is the Medical Director, Pinnacle Clinical Research in San Antonio, Texas. He is a Gastroenterologist and Hepatologist specializing in NASH clinical research. Dr. Harrison most recently served as a Colonel in the United States Army, retiring in 2016. During his army tenure, he served as the Director of Army Graduate Medical Education at Brooke Army Medical Center, Associate Dean for the San Antonio Uniformed Services Health Education Consortium and Gastroenterology Consultant to the Army Surgeon General. He is also currently serving as a Visiting Professor of Hepatology at the University of Oxford, UK. .

H. James Harwood, PhD

Dr. Harwood is a former Principal Research Investigator at Pfizer. Currently, he is the Founder and Chief Consultant at Delphi BioMedical Consultants LLC, Adjunct Professor Department of Cell and Molecular Biology and Health Professions Advisory Committee Member at the University of Rhode Island, and Adjunct Professor Department of Pathology at Wake Forest University. Jim brings more than 30-year experience in drug R&D in pharmaceutical industry especially in physiology and pharmacology of metabolic and cardiovascular diseases.

William A. Haseltine, PhD

Dr. Haseltine has an active career in science, business and philanthropy. He was a professor from 1976-1993 at Harvard University where he was the Founder and Chair of the Division of Biochemical Pharmacology and the Division of Human Retrovirology. He is well known for his pioneering work on cancer, HIV/AIDS and genomics. He has authored more than 200 manuscripts in peer reviewed journals. He is a pioneer in biotechnology having founded twelve biotechnology companies in fields ranging from development of cutting edge pharmaceuticals to new materials and fuels. He is the Founder of Human Genome Sciences, Inc. and served as the Chairman and CEO of the Company for twelve years. Eight pharmaceutical products from companies he founded are currently approved by US and international regulatory agencies. He is Chair and President of ACCESS Health International, a foundation active in the United States, India, China, Singapore, the Netherlands and the Philippines. He is also Chairman of the Haseltine Foundation for Science and the Arts.

Allen Ritter, PhD

Dr.Ritter is an experienced leader in the development, registration, manufacture and outsourcing of the manufacture of pharmaceuticals. Over 30 years of experience, including previous roles as VP, CMC/Manufacturing at Endocyte, Inc. and multiple positions at Eli Lilly and Co.

Arun J. Sanyal, MD

Dr. Sanyal is the Professor, Division of Gastroenterology, Hepatology and Nutrition. Virginia Commonwealth University. He has over 25 years of experience as a hepatologist and has served as the secretary and president of the American Association for Study of Liver Diseases, founding member of the Hepatology board of the American Board of Internal Medicine, chair of the NIH hepatobiliary pathophysiology study section and member of the council of the NIH. He has helped establish and chair the “Liver Forum” which brings FDA, European Medical Agency, Academia, NIH and industrystakeholders in NASH and hepatic fibrosis together to accelerate therapeutic development in these areas.